29 results on '"Kamamoto, Sae"'
Search Results
2. Financial conflicts of interest in Japanese obstetrics and gynaecology clinical practice guidelines
3. Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019
4. Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021
5. Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
6. Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
7. Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021
8. Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
9. Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019
10. Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors’Self‐CitationRate in Japan and the United States
11. Pharmaceutical Payments to Japanese Board‐Certified Head and Neck Surgeons Between 2016 and 2019
12. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines
13. The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
14. Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic
15. Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020
16. Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
17. Trend in Industry Payments to Rheumatologists in the United States During the COVID-19 Pandemic Between 2013 and 2021
18. Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society
19. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross‐sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019
20. Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
21. Evaluation of Industry Payments to Allergists and Clinical Immunologists in the United States during the COVID-19 pandemic: A Seven-year analysis of the Open Payments Database from 2014 to 2020
22. HPV vaccination and cervical cancer screening
23. Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
24. Pharmaceutical Payments to Japanese Board-certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
25. Nature and Trends of Pharmaceutical Payments to Board Certificated Respiratory Specialists in Japan between 2016 and 2019
26. Pharmaceutical Payments to Japanese Certificated Hematologists: A Retrospective Analysis of Personal Payments from Pharmaceutical Companies between 2016 and 2019
27. Pharmaceutical Payments to Japanese Certificated Pediatric Hematologist/Oncologists: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019
28. Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
29. Ubiquitin-like 3 as a new protein-sorting factor for small extracellular vesicles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.